PubHawk
Biotechnol Bioeng February 2022 PMID 34796474

Rapid cGMP manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools.

Rita Agostinetto, Mara Rossi, Jessica Dawson, Angela Lim, Mirva H Simoneau, Cyril Boucher, Bernhard Valldorf, Adin Ross-Gillespie, Joseph G Jardine, Devin Sok, Dennis R Burton, Thomas Hassell, Hervé Broly, Wolf Palinsky, Philippe Dupraz

Download social card

Mentions

9
Peak: 2 in Aug 2023
across 4 sources since May 2022

Extended reach

336
potential audience

Total likes

0

Video views

168

Mentions per month

May 2022 – Dec 2025

Where it's discussed

  • News4 articles
  • X / Twitter2 posts
  • YouTube2 videos
  • TikTok1 posts

AI synopsis

What people are saying

Discussions highlight the rapid production process enabled by the Leap-In Transposase® system, with users describing it as a 'game-changer' or 'major breakthrough,' which conveys optimism and acknowledges the method's transformative potential, while the tone remains generally supportive and curious.

AgreementModerate agreement

Most discussions express support or approval of the study’s findings on rapid manufacturing techniques.

InterestModerate interest

Participants show a moderate level of interest, mentioning the potential benefits and innovations without deep technical dives.

EngagementNeutral engagement

There is some engagement, with users asking questions or commenting on the significance but few detailed discussions.

ImpactModerate impact

The posts suggest the research could have meaningful implications for vaccine and therapeutic production, contributing positively to the field.

Abstract in brief

  • Therapeutic proteins, such as monoclonal antibodies, traditionally require the development of stable host cell lines, which is a time-consuming process that can delay new treatments.
  • During the COVID-19 pandemic, a new approach using the Leap-In Transposase® system allowed for the rapid creation of stable pools for manufacturing an anti-SARS-CoV-2 monoclonal antibody.
  • This expedited process enabled the production of clinical trial material in just 4.5 months, significantly faster than the usual 12-14 month timeline, while ensuring that product quality met all necessary specifications.
Read the full abstract

Top posts

Most liked on X and Bluesky
Ugg0001
@ugg0001 · X

@robinmonotti @jjcouey @CatherineOrgan4 https://t.co/HA2vAGvRks

Aug 30, 2023 · 59 followers View post →
Ugg0001
@ugg0001 · X

@jjcouey https://t.co/HA2vAGvRks

Aug 30, 2023 · 59 followers View post →

All mentions

Ugg0001
@ugg0001 · X

@robinmonotti @jjcouey @CatherineOrgan4 https://t.co/HA2vAGvRks

Aug 30, 2023 · 59 followers View post →
Ugg0001
@ugg0001 · X

@jjcouey https://t.co/HA2vAGvRks

Aug 30, 2023 · 59 followers View post →
7006 | PDF | Business | Finance & Money Management
News

10.7554/eLife.27995 10.1557/mrc.2018.124 10.1038/nm0999_975 10.1536/ihj ... 10.1002/bit.26569 10.18433/jpps29893 10.1177/1479164118786969 10.1590/S0103 ...

Dec 29, 2025 View →
High-fidelity and high-speed wavefront shaping by leveraging ...
News

For example, LC-SLMs feature high-precision (8 to 12 bits) phase modulation and have been demonstrated for high-fidelity wavefront shaping in ...

Jul 3, 2024 View →
Understanding the Science Behind Fruit Cleaner Devices | TikTok
TikTok

27,995 07,94:454!850 At Quest Appliances we deal with Electronics ... bit lighter. Link in bio to order #goodlifstores #naijatiktok ...

Jun 2, 2023 View →
Science Magazine, Issue 6638 (March 24, 2023) | PDF
News

by December 31, 2023. bit.ly/NewsFromScience. CONTENTS. 24 ... Signs of volcanic activity glacier's wake 10.1002/ecs2.4404. Science ...

Mar 24, 2023 View →
Cell-Line Engineering and Development - BioProcess International
News

https://doi.org/10.1002/bit.27995. 3 Zhang Z, et al. Reshaping Cell Line Development and CMC Strategy for Fast Responses to Pandemic ...

May 24, 2022 View →